Exelixis
EXEL
#1759
Rank
โ‚ฌ9.77 B
Marketcap
36,30ย โ‚ฌ
Share price
1.36%
Change (1 day)
11.63%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no stock splits for this company